title: [Antibiotic therapy of mild community-acquired pneumonia in inpatients].
abstract: From the clinicoeconomic viewpoints the treatment of community-acquired pneumonia in patients without risk factors under hospital conditions with aminopenicillins was more appropriate, whereas for the treatment of patients with risk factors the following scheme of antibiotic therapy was advantageous: a beta-lactam (cefotaxime/ceftriaxone) in combination with a macrolide (azithromycin). The recommended therapy provided statistically lower percentage of negative pneumonia processes and decreased the treatment expenditures.
authors.forename: O V
authors.initials: OV
authors.lastname: Molchanova
authors.forename: S Sh
authors.initials: SSh
authors.lastname: Suleĭmanov
authors.forename: A B
authors.initials: AB
authors.lastname: Ostrovskiĭ
mesh_terms: D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000191:economics; D003141:Communicable Diseases / Q000188:drug therapy* / Q000191:economics / Q000453:epidemiology; D005260:Female; D006801:Humans; D007297:Inpatients; D008297:Male; D011014:Pneumonia / Q000188:drug therapy* / Q000191:economics / Q000453:epidemiology; D012189:Retrospective Studies
chemical_list: D000890:Anti-Infective Agents